Source: International Congress 2019 – New recommendations and priorities for asthma management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Johnston (London, United Kingdom). Asthma attacks: pathogenesis and therapeutic implications. International Congress 2019 – New recommendations and priorities for asthma management

Member's Comments

No comment yet.

Related content which might interest you: Clinical implications of the new concepts regarding COPD pathophysiology Source: Annual Congress 2008 - New insights into COPD pathophysiology Year: 2008 Mechanisms of COPD exacerbations - molecular perspectives and pathophysiology Source: ERS Satellites 2021 Year: 2021 Asthma susceptibility: from pathophysiology to personalised medicine Source: International Congress 2015 – ME4 Asthma susceptibility Year: 2015 International perspectives on severe asthma: Current and future challenges in patient care Source: International Congress 2016 – Asthma points to ponder Year: 2016 The consequences of novel insights into the pathophysiology of asthma for its treatment Source: Annual Congress 2008 - Should asthma no longer be considered an allergic disease? Year: 2008 The role of antioxidant enzymes in the pathogenesis of asthma and the formation of the features of its clinical course Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Clinical course of childhood asthma: a role of disease severity Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008 Identifying patients at risk for future exacerbations of asthma: Development of a prediction model Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Identification of therapeutic targets for steroid-insensitive asthma using models that represent different clinical subtypes of disease Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Asthma with hyperventilation: new therapeutical possibility Source: Eur Respir J 2002; 20: Suppl. 38, 56s Year: 2002 Assessing asthma risk in primary care: Can the AAA test predict future asthma attacks? Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Bacterial immunotherapy in children with wheezing attacks: clinical impact and mechanism of action Source: International Congress 2019 – Novel findings in paediatric respiratory infections Year: 2019 The role of biomarkers in the management of severe asthma Source: International Congress 2019 – Severe asthma guidelines: update 2019 Year: 2019 Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 The potential role of bronchial challenge testing to identify overtreatment of community managed asthma Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children Source: Eur Respir J 2006; 28: Suppl. 50, 481s Year: 2006 CompEx – A novel composite asthma exacerbation endpoint Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 Late Breaking Abstract: An animal model for studies on pathogenesis and pharmaceutical intervention of chronic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010